Omthera Pharma reaches agreement with FDA on Epanova SPA
Epanova is an Omega 3 fatty acid containing a new formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Omthera Pharma said that the multi-center, placebo-controlled, randomised, double-blind,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.